We've built an unbiased platform that lets data drive decisions, not us, says Recursion CEO

Recursion Pharmaceuticals Co-Founder and CEO Chris Gibson joins 'Mad Money' host Jim Cramer to talk integrating machine learnings into drug development and partnering with Nvidia.